A detailed history of Massmutual Trust CO Fsb transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 86 shares of LGND stock, worth $10,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86
Previous 86 -0.0%
Holding current value
$10,552
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 03, 2024

BUY
$49.57 - $72.63 $4,263 - $6,246
86 New
86 $6,000
Q1 2023

Apr 11, 2023

BUY
$65.67 - $77.08 $853 - $1,002
13 New
13 $0
Q3 2022

Oct 07, 2022

BUY
$0.01 - $107.56 $0 - $1,720
16 New
16 $1,000
Q4 2019

May 15, 2020

SELL
$96.94 - $113.59 $373,509 - $437,662
-3,853 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$86.25 - $120.16 $10,867 - $15,140
-126 Reduced 3.17%
3,853 $384,000
Q2 2019

Aug 14, 2019

BUY
$107.38 - $129.34 $407,936 - $491,362
3,799 Added 2110.56%
3,979 $454,000
Q1 2019

May 15, 2019

SELL
$105.93 - $142.47 $3,283 - $4,416
-31 Reduced 14.69%
180 $22.6 Million
Q4 2018

Feb 26, 2019

SELL
$128.36 - $272.13 $2,182 - $4,626
-17 Reduced 7.46%
211 $28.6 Million
Q3 2018

Nov 09, 2018

SELL
$211.18 - $274.49 $531,328 - $690,616
-2,516 Reduced 91.69%
228 $62.6 Million
Q2 2018

Aug 20, 2018

BUY
$150.77 - $207.98 $22,917 - $31,612
152 Added 5.86%
2,744 $568 Million
Q1 2018

May 21, 2018

BUY
$138.63 - $182.62 $57,115 - $75,239
412 Added 18.9%
2,592 $428 Million
Q4 2017

Mar 01, 2018

SELL
$128.36 - $147.04 $13.1 Million - $15 Million
-102,116 Reduced 97.91%
2,180 $299 Million
Q4 2017

Feb 21, 2018

BUY
$128.36 - $147.04 $13.1 Million - $15 Million
102,174 Added 4814.99%
104,296 $2.69 Billion
Q3 2017

Feb 13, 2018

BUY
$120.91 - $137.94 $11,244 - $12,828
93 Added 4.58%
2,122 $289 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,029
2,029 $246 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.07B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.